当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 现金流量表

特宝生物

(688278)

  

流通市值:241.24亿  总市值:241.24亿
流通股本:4.08亿   总股本:4.08亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金983,596,732.233,370,745,401.212,454,222,650.871,609,290,713.9
  收到的税费返还-1,053,779.861,053,779.861.4
  收到其他与经营活动有关的现金16,455,316.2939,063,145.2830,954,046.7520,440,741.78
  经营活动现金流入小计1,000,052,048.523,410,862,326.352,486,230,477.481,629,731,457.08
  购买商品、接受劳务支付的现金62,984,102.21273,886,111.15186,343,062.4188,983,339.77
  支付给职工以及为职工支付的现金381,606,611.49947,436,617.8686,802,192.98450,478,475.84
  支付的各项税费153,223,681.09263,713,378.45191,176,718.99142,204,355.18
  支付其他与经营活动有关的现金267,855,445.971,196,450,350.09950,790,296.4587,519,873.82
  经营活动现金流出小计865,669,840.762,681,486,457.492,015,112,270.781,269,186,044.61
  经营活动产生的现金流量净额134,382,207.76729,375,868.86471,118,206.7360,545,412.47
二、投资活动产生的现金流量:
  收回投资收到的现金601,931,826.711,559,427,565.981,047,638,167.17846,874,667.36
  处置固定资产、无形资产和其他长期资产收回的现金净额760745,790.5321,90021,300
  收到的其他与投资活动有关的现金9,215,949.87---
  投资活动现金流入小计611,148,536.581,560,173,356.511,047,660,067.17846,895,967.36
  购建固定资产、无形资产和其他长期资产支付的现金74,873,480.2256,143,258.1168,636,047.1998,678,266.44
  投资支付的现金267,000,0001,745,966,623.841,178,394,721.08695,000,000
  取得子公司及其他营业单位支付的现金-58,394,721.08--
  投资活动现金流出小计341,873,480.22,060,504,603.021,347,030,768.27793,678,266.44
  投资活动产生的现金流量净额269,275,056.38-500,331,246.51-299,370,701.153,217,700.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金-54,439,826.454,439,826.4-
  取得借款收到的现金41,500,000140,670,352.2120,000,00010,000,000
  筹资活动现金流入小计41,500,000195,110,178.6174,439,826.410,000,000
  偿还债务支付的现金27,616,299.4---
  分配股利、利润或偿付利息支付的现金613,691.66252,874,306.73252,387,208.33252,362,208.33
  支付其他与筹资活动有关的现金3,417,140.179,393,732.255,970,558.544,420,102.39
  筹资活动现金流出小计31,647,131.23262,268,038.98258,357,766.87256,782,310.72
  筹资活动产生的现金流量净额9,852,868.77-67,157,860.38-83,917,940.47-246,782,310.72
四、汇率变动对现金及现金等价物的影响-24,947.16-549,425.9-201,057.26170,763.63
五、现金及现金等价物净增加额413,485,185.75161,337,336.0787,628,507.87167,151,566.3
  加:期初现金及现金等价物余额522,853,034.5361,515,698.43361,515,698.43361,515,698.43
  期末现金及现金等价物余额936,338,220.25522,853,034.5449,144,206.3528,667,264.73
补充资料:
  净利润-1,031,236,252.58-427,894,111.21
  固定资产和投资性房地产折旧-67,097,292.45-23,156,309.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-67,097,292.45-23,156,309.38
  无形资产摊销-49,189,014.34-20,423,225.35
  长期待摊费用摊销-21,405,483.71-6,166,068.79
  处置固定资产、无形资产和其他长期资产的损失-718,026.13--21,300
  固定资产报废损失-269,228.25-242,604.15
  公允价值变动损失--3,448,015.83--590,535.23
  财务费用-1,971,417.52-209,203.06
  投资损失--6,599,263.41--1,873,297.19
  递延所得税--21,659,765.43--3,070,583.72
  其中:递延所得税资产减少--28,422,780.7--3,121,936.16
    递延所得税负债增加-6,763,015.27-51,352.44
  存货的减少--164,064,868.87--57,645,754.59
  经营性应收项目的减少--405,579,582.89-4,504,566.2
  经营性应付项目的增加-88,480,145.44--87,684,247.3
  其他-61,855,511.2-26,392,458.89
  现金的期末余额-522,853,034.5-528,667,264.73
  减:现金的期初余额-361,515,698.43-361,515,698.43
  现金及现金等价物的净增加额-161,337,336.07-167,151,566.3
公告日期2026-04-292026-03-272025-10-232025-08-21
审计意见(境内)标准无保留意见
TOP↑